NCT04953923View on ClinicalTrials.gov

Thorough QT Assessment of Cedazuridine in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

July 1, 2021

Primary Completion Date

November 15, 2021

Study Completion Date

November 16, 2021

Conditions
Healthy Volunteers
Interventions
DRUG

Cedazuridine

Tablet for oral administration

DRUG

Placebo

Capsule for oral administration

DRUG

Moxifloxacin

Tablet for oral administration

Trial Locations (1)

9472NZ

PRA Health Sciences, Groningen

Sponsors
All Listed Sponsors
lead

Astex Pharmaceuticals, Inc.

INDUSTRY